Blogs
Natalia Dovlatova’s career journey
Recently we sat down with Platelet Services CEO Natalia Dovlatova to discuss her career journey and plans for the future of the company. Before Platelet
Platelet research continues to flourish!
Towards the end of April, four of the Platelet Services team were delighted to travel to Aberdeen for the annual Platelet Society meeting. This group
Oral antiplatelet therapy – half a century of evolution
It is now 50 years since the first randomised, controlled trial of aspirin in the secondary prevention of mortality from myocardial infarction (MI)[1]. Although the
Celebrating our fifth anniversary
Recently we celebrated five years as Platelet Services and in this blog we are looking back on some of our highlights over the last five
American College of Toxicology (ACT) 44th Annual Meeting: post event round-up
Platelet Services’ Natalia Dovlatova and Charlotte Jewell recently spent several days in Orlando, Florida while attending the American College of Toxicology (ACT) 44th Annual Meeting
Therapeutic antibodies can have an effect on platelet function
Monoclonal antibodies (mAbs) are being discovered and developed as new therapeutic approaches to combat different diseases such as cancers, autoimmune diseases, HIV and more. Some
